Vanhoutte Paul M (168 results)

hardcover. Condition: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority.

Condition: Good. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

gebundene Ausgabe. Condition: Gut. 337 Seiten; Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sauber. Es befindet sich neben dem Rückenschild lediglich ein Bibliotheksstempel im Buch; ordnungsgemäß entwidmet. Einbandkanten sind leicht bestoßen. In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 880.…

Hardcover. Condition: As New. Leichte Kratzer / Abnutzungen / Druckstellen. Understanding the nature and role of endothelium-derived hyperpolarizing factor appears to be crucial in the quest for improved treatments for hypertension, diabetes, ischemia-reperfusion and other vascular disorders. EDHF 2002 contains the proceedings of the Fourth International Symposium on endothelium-dependent hyperpolarizations and will be of interest not only to physiologists and pharmacologists puzzled by the complexity of the interactions between the endothelium and underlying vascular smooth muscle cells, but also clinical researchers and physicians treating patients with cardiovascular diseases.…

Condition: very_good. Gently read. May have name of previous ownership, or ex-library edition. Binding tight; spine straight and smooth, with no creasing; covers clean and crisp. Minimal signs of handling or shelving. 100% GUARANTEE! Shipped with delivery confirmation, if you're not satisfied with purchase please return item! Ships USPS Media Mail.…

Hardcover. Condition: Near Fine. 380555091X. Pictorial board hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed. 338 pages, index, illustrated with charts, tables and diagrams. Contents clean, tight and bright. Book.

Hardcover. Condition: Very Good. 380555091X. Pictorial board hardcover, from closed pharmaceutical company library. 338 pages, index, illustrated with charts, tables and diagrams. Contents clean, tight and bright. Book.

Hard Cover. Condition: Very Good+. Dust Jacket Condition: Very Good. First. No internal inscriptions. Interior very clean. Exterior boards very clean. Dustwrapper not price clipped but has minor rips at top of spine Quantity Available: 1. Shipped Weight: Under 1 kilogram. Category: Medicine & Health; ISBN: 0881671010. ISBN/EAN: 9780881671018. Pictures of this item not already displayed here available upon request. Inventory No: 000635. …

Hardcover. Condition: Good. No Jacket. First Edition. From a University library with the usual stamps and labels. Some light wear and a pale splashmark on the front board. A00002049.

Condition: New.

Hardcover. Condition: Near Fine. No Jacket. 0897664191. Blue cloth hardcover, from closed pharmaceutical company library. 802 pages, index. Contents clean, tight and bright, appears unread. Book.

Condition: Fine. Amsterdam 1999. Harwood. Hardcover. Sm.4to., 436pp., illus., index, printed boards. Fine. as new.

Hardcover. Condition: Very Good. Scarce hardcover, x + 134 pages, glossy paper, index, NOT ex-library. Interior in very good condition: clean, bright, untanned, with unmarked text and tight binding, free of readily noticeable creasing. Boards gently shelfworn showing short creases/bumps to edges and wrinkles to spine ends, faint marks and scratches, limited scuffing. Published without a dust jacket. --- The data presented and discussed in this monograph support the concept of heart rate reduction as a valuable therapeutic option for reducing morbidity and mortality in a wide range of cardiovascular disease. Clinical evidence has been accumulating for many years to suggest a link between heart rate and mortality in patients with coronary artery disease, as well as in the general population. Epidemiologic data, particularly from the Framingham study, have also indicated a strong link between sudden cardiac death and sustained elevated heart rate, raising the issue that slow heart rate per se might exert an antifibrillatory action. In this respect, an elevated heart rate can be considered as an independent risk factor for cardiovascular mortality. There is also evidence to suggest that a sustained elevated heart rate may play a direct role in the pathogenesis of coronary atherosclerosis. It is widely accepted that lowering heart rate can reduce the risk of cardiovascular events and increase life expectancy.The heart rate-lowering effects of beta blockers have been correlated with reduced cardiovascular and total mortality in post-myocardial infarction and heart failure patients. In theory, a highly specific heart rate-lowering agent should have the same beneficial effects with respect to reduced risk and mortality and may avoid some of the drawbacks associated with beta blocker therapy. The objectives of current therapies are to increase coronary blood flow and decrease myocardial oxygen demand. Heart rate is a critical determinant of myocardial oxygen consumption and a reduction in heart rate usually leads to a reduction in myocardial oxygen consumption. Coronary blood flow can be improved by a slower heart rate due to an increase in diastolic perfusion time during the heart cycle. The role of specific heart rate-lowering agents needs to be explored in this context.…

Condition: As New. Unread book in perfect condition.

xv + 288pp.with ills., cart.with dustwrapper, VG.

First edition. Red cloth-covered boards, gilt spine lettering, 9 1/2 x 6 1/4 inches, 288 pp., references (extensive; pp. 231-280), index, figures and tables. Book and dustcover fine. Multiple contributors.

PF. Condition: New.

PF. Condition: New.

Condition: New.

Condition: New. In English.

Hardcover. Condition: Good. Good condition (stain on cover, book itself in good condition) Hardcover, no dust jacket.

Condition: New. In English.

Condition: good. A copy that has been read, remains in good condition. All pages are intact, and the cover is intact. The spine and cover show signs of wear. Pages can include notes and highlighting and show signs of wear, and the copy can include "From the library of" labels or previous owner inscriptions. 100% GUARANTEE! Shipped with delivery confirmation, if you're not satisfied with purchase please return item! Ships via media mail.…

Condition: New. pp. 176.

Paperback. Condition: Brand New. 176 pages. 10.00x7.01x0.42 inches. In Stock.

Hardcover. Condition: Like New. Like new hrdbk w/ decorative covers; no markings whatsoever save name written on edge of pages along btm.; vol. is Prcdngs. of the invited lectures of the 1st intl. Symp. on Seratonin from cell bio.

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Although the importance of calcium (Ca2+) in the maintenance of cardiac contractility was recognized as early as 1880, the critical role of the ion in the contractile process in skeletal, cardiac, and smooth muscle has only been established within the last three decades. As the complexity of the pharmacological actions of the Ca2+ channel inhibitors grows, there is a continued need to further clarify the inhibitors, both chemically and functionally. This volume provides an update of the field based on the work presented at the 5th International Symposium on Calcium Antagonists: Pharmacology and Clinical Research. It reviews the current state of the growing area of molecular biology of Ca2+ channels. In the cardiovascular area, in addition to the well-established clinical uses of Ca2+ channel inhibitors, exciting new work pointing to an application in atherosclerosis is described. The book also includes important uses of Ca2+ antagonists in novel areas of interest such as the gastrointestinal tract, renal protection and multi-drug resistance.…

Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - MOTOOMI NAKAMURA As we approach the 21st century, ischemic heart disease is the major cause of death in most of the developed nations of the world. Since the 1970s, much effort and expense have led to designs of coronary thrombolytic therapy, percutaneous coronary angioplasty (PTCA), coronary artery bypass grafting, heart transplantation, automatic defibrillators, as well as to the formation of beta blockers and com pounds which block the calcium channel. Socio-educational programs directed at exercise, diet, instruction in the risk factors of smoking, hyperlipidemia and hypertension have contributed to the decrease in the rate of morbidity and mortality of patients with ischemic heart disease. However, the first clinical event of ischemic heart disease, the so-called 'heart attack' and sudden cardiac death continues to present problems, as the mechanisms involved in these events are poorly understood. It has long been thought that ischemic heart disease is the sequence of an organic fixed atherosclerotic obstruction of the epicardial coronary arteries and the role of coronary vasomotion has been given much less attention. Recent clinical and laboratory animal studies revealed that increased tonus and spasm of the large epicardial coronary arteries are the cause of various stages of ischemic heart disease. The role of coronary vasospasm in the development of un stable angina, sudden cardiac death and acute myocardial infarction remains open to debate. Pharmacophysiological studies showed that the epicardial large coronary artery contributes only 5% to regulation of normal coronary flow.…

Condition: New. pp. 414.

Condition: As New. Unread book in perfect condition.